Grant: Collaborative Health Research Projects
University of Manitoba
$73,334.00
Development of magnetic nanoparticles to breakthrough the blood-brain barrier
EF 2013-14
Résumé
Effective treatment of brain related disorders requires an adequate distribution of drugs into the brain. For many drugs,penetration into the brain is restricted by the brain capillaries that form what is referred to as the blood-brain barrier (BBB).The current research project will develop iron-oxide based nanoparticles as a delivery platform for enhancing the brainpenetration of drugs. Our approach is to utilize the magnetic properties of the nanoparticles to ""pull"" them through the BBBby applying a magnetic field to the brain. Optimization of the outer surface properties of the magnetic nanoparticles will beperformed to target the nanoparticles to the junctions between the brain capillary endothelial cells which in the presence of amagnetic field will enhance BBB penetration. Once optimization is achieved, studies will be preformed to determine the biocompatibilityand safety profile of these magnetic nanoparticles at both the cell culture and whole animal (mouse) level. Thisis important as the potential brain related toxicity of these particular nanoparticles is unknown. Finally, using a prototypemagnetic nanoparticle, we will perform proof-of-principle studies demonstrating the increased delivery of chemotherapeuticagents to target sites in a mouse brain tumor model. Our overall objective is to determine the optimal surface properties andmagnetic field strengths to achieve brain penetration, as well as to characterize the bio-compatibility and safety profile ofthese magnetic nanoparticles for brain related applications.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
446420-2013
Name nom
Miller, Donald
Department département
Pharmacology and Therapeutics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
73334
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Development of magnetic nanoparticles to breakthrough the blood-brain barrier
Keyword
NSERC
Application summary
Effective treatment of brain related disorders requires an adequate distribution of drugs into the brain. For many drugs,penetration into the brain is restricted by the brain capillaries that form what is referred to as the blood-brain barrier (BBB).The current research project will develop iron-oxide based nanoparticles as a delivery platform for enhancing the brainpenetration of drugs. Our approach is to utilize the magnetic properties of the nanoparticles to ""pull"" them through the BBBby applying a magnetic field to the brain. Optimization of the outer surface properties of the magnetic nanoparticles will beperformed to target the nanoparticles to the junctions between the brain capillary endothelial cells which in the presence of amagnetic field will enhance BBB penetration. Once optimization is achieved, studies will be preformed to determine the biocompatibilityand safety profile of these magnetic nanoparticles at both the cell culture and whole animal (mouse) level. Thisis important as the potential brain related toxicity of these particular nanoparticles is unknown. Finally, using a prototypemagnetic nanoparticle, we will perform proof-of-principle studies demonstrating the increased delivery of chemotherapeuticagents to target sites in a mouse brain tumor model. Our overall objective is to determine the optimal surface properties andmagnetic field strengths to achieve brain penetration, as well as to characterize the bio-compatibility and safety profile ofthese magnetic nanoparticles for brain related applications.